EHD {EH [Eps15 (epidermal growth factor receptor substrate 15) homology]-domain-containing} proteins participate in several endocytic events, such as the internalization and the recycling processes. There are four EHD proteins in mammalian cells, EHD1-EHD4, each with diverse roles in the recycling pathway of endocytosis. EHD2 is a plasma-membrane-associated member of the EHD family that regulates internalization. Since several endocytic proteins have been shown to undergo nucleocytoplasmic shuttling and have been assigned roles in regulation of gene expression, we tested the possibility that EHD proteins also shuttle to the nucleus. Our results showed that, among the three EHD proteins (EHD1-EHD3) that were tested, only EHD2 accumulates in the nucleus under nuclear export inhibition treatment. Moreover, the presence of a NLS (nuclear localization signal) was essential for its entry into the nucleus. Nuclear exit of EHD2 depended partially on its NES (nuclear export signal).
INTRODUCTION
EHD {EH [Eps15 (epidermal growth factor receptor substrate 15 ) homology]-domain-containing} proteins participate in various membrane-associated endocytic events, including the internalization steps of endocytosis and recycling [1] . Mammalian cells express four highly homologous EHD proteins (EHD1-EHD4), one EHD orthologue exists in Drosophila [Past1 (putative achaete scute target-1)] [2] and Caenorhabditis elegans [RME-1 (receptor-mediated endocytosis-1)] [3] , and two genes are present in plants [AtEHD1 (Arabidopsis thaliana EHD-1) and AtEHD2] [4, 5] . All metazoan EHD proteins contain a nucleotide-binding consensus sequence at their N-terminus, a helical central domain and an EH motif at their C-terminus [1] . In plants, the EH domain precedes the NTP-binding motif [4] . Despite their high homology (between 70-86 %), the four mammalian EHD proteins localize to different cellular organelles and have diverse functions in various stages of endocytosis [1, 6] . In particular, EHD2 localizes to the plasma membrane. Its overexpression as well as its downregulation was shown to cause inhibition of internalization [7] [8] [9] [10] .
The EH domain is a highly conserved structure, containing ∼100 amino acids. It consists of two EF-hand (calcium-binding domain) helix-loop-helix motifs bridged by a short antiparallel β-sheet [11, 12] . The EH domain binds the asparagine-prolinephenylalanine (NPF) tripeptide [11] . EHD proteins undergo nucleotide-binding-dependent hetero-oligomerization, probably through their helical domains [6] . EHD2 is the only member that also forms homodimers, owing to the presence of a GPF motif in its N-terminal helical domain. The GPF motif of one EHD2 molecule binds the EH domain of a second molecule, such that the two opposing EHD2 monomers face each other in a head-head manner [12] . The ability of EHD proteins to undergo heterooligomerization as well as oligomerization of dimers (in the case of EHD2) allows the creation of highly curved membrane-binding regions in the proteins, which can cause membrane bending and have subsequent effects on the fusion/fission events during endocytosis [12, 13] .
Along with the classical roles of known endocytic proteins in regulating intracellular trafficking, new functions of these proteins inside the nucleus have emerged [14] . One of the EHdomain-containing proteins, Eps15, and its interactor, Epsin1, were shown to accumulate in the nucleus upon nuclear export inhibition, using LMB (leptomycin B) [14] . Other proteins, which constitute the endocytic machinery, such as Dab2 (disabled homologue 2), β-arrestins and CALM (clathrin assembly lymphoid myeloid leukaemia) were also documented as nucleocytoplasmic shuttling proteins [14] . Moreover, several endocytic proteins were suggested to have a role in transcription regulation and chromatin remodelling [14] . Thus β-arrestin1 was shown to function as a scaffold for transcription factors following GPCR (G-protein-coupled receptor) stimulation [15] . The ability of Dab2 to increase TGFβ (transforming growth factor β)-mediated gene transcription was detected as well [16] .
Nucleocytoplasmic transport of proteins larger than 50-60 kDa requires the presence of NLS (nuclear localization signal) and NES (nuclear export signal) sequences, which are recognized by the karyopherin family of transporters, which includes importins and exportins [17] . Importins recognize NLS sequences in proteins and transfer them into the nucleus, whereas exportins recognize NES sequences within proteins and guarantee their transport to the cytoplasm [18] . Both transporters transfer their cargo from one side of the nuclear envelope to the other in a RanGTP-dependent manner. The interaction between one of the prevalent exportins, CRM1 (chromosomal region maintenance 1), and NES can be inhibited by the antifungal drug LMB, causing nuclear accumulation of the shuttling proteins [19] .
Modification of proteins by SUMO (small ubiquitin-like modifier) is tightly involved in nucleocytoplasmic trafficking of proteins [20] . A known SUMO-acceptor site in proteins is ψKxE (in which ψ is an aliphatic branched amino acid and x is any amino acid). The SUMOylation cycle resembles the ubiquitylation process and starts with SUMO activation by two SAEs (SUMO-activating enzymes), SAE1 and SAE2, which form heterodimers. Activated SUMO proteins are transferred to a specific SUMO-conjugating enzyme, known as UBC9 (ubiquitinlike protein SUMO1 conjugating enzyme), and finally reach the lysine residues in target proteins [20] . One of the main features of SUMOylation is rapid deconjugation of SUMO from its substrate by specific endopeptidases, designated SENPs [SUMO1/sentrin/SMT3 (suppressor of mif two 3 homologue 1)-specific peptidases]. Only a small fraction of a SUMOylated substrate can be found at any given time [21] .
In the present study we tested whether EHD1, EHD2 or EHD3 shuttle to the nucleus. Our results showed that only EHD2 accumulated in the nucleus following LMB-induced inhibition of nuclear exit, and its entry to the nucleus was NLS-dependent. Elimination of a potential SUMOylation site in EHD2 caused major accumulation of the protein in the nucleus, indicating the involvement of SUMOylation in nuclear exit of EHD2. Our results strongly indicated that nuclear EHD2 functions as a transcriptional corepressor.
EXPERIMENTAL

Antibodies
The primary antibodies used in the present study were: polyclonal anti-GFP (green fluorescent protein) (Santa Cruz Biotechnology); mouse anti-Myc (Cell Signaling Technology); polyclonal anti-EHD2 (a gift from Dr Steve Caplan, Department of Biochemistry and Molecular Biology, Nebraska University, Omaha, Nebraska, U.S.A.); polyclonal anti-EHD2 (Abcam); monoclonal anti-β-tubulin (Sigma); polyclonal anti-(lamin A/C) (Cell Signaling Technology); polyclonal anti-HA (haemagglutinin) (Santa Cruz Biotechnology) and polyclonal anti-SUMO1 (Abcam). The secondary antibodies used in the present study were: Cy3 (indocarbocyanine)-conjugated goat anti-rabbit, horseradishperoxidase-conjugated goat anti-mouse, goat anti-rabbit and donkey anti-goat (Jackson Immuno Research Laboratories).
Cell lines
HeLa, HEK (human embryonic kidney)-293T and COS7 cells were grown in DMEM (Dulbecco's modified Eagle's medium; Gibco), supplemented with 10 % FBS (fetal bovine serum; Beit-Haemek). All cells were grown at 37
• C in the presence of 5 % CO 2 .
Plasmids
GFP-EHD1, GFP-EHD2, GFP-EHD3 and Myc-EHD2 were prepared as described previously [10] . To create a MoKA [modulator of KLF7 (Krüppel-like factor 7) activity]-expressing plasmid, a MoKA-containing fragment isolated from GFPMoKA [22] using SalI and StuI, was cloned into the XhoI site of pCMV-NEO-BAM-Myc vector (a gift from Professor Sima Lev, Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel). HA-SUMO1 was a gift from Professor Michael Nevels (Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany). To create mutant forms of EHD2, in vitro site-directed mutagenesis was performed using the QuikChange site-directed mutagenesis kit (Stratagene Life Technologies), according to the manufacturer's instructions.
Transfections
HeLa and COS7 cells were transfected using FuGENE ® 6 transfection reagent (Roche Diagnostics) or TransIT ® -LT1 Reagent (Mirus Bio), according to the manufacturer's instructions. HEK-293T cells were transfected using the calcium phosphate method. Briefly, a mixture of DNA in 250 μl of 250 mM CaCl 2 was dropped into a tube containing 250 μl of 2×HBS solution (50 mM Hepes, 280 mM NaCl and 1.5 mM Na 2 HPO 4 , pH 7.09) and incubated for 20 min at room temperature. The mixture was then added dropwise to subconfluent cells, and incubated for 6 h to overnight, after which the medium was replaced with fresh medium.
SDS/PAGE and Western blotting
Cell monolayers were washed three times with ice-cold PBS and lysed at 4
• C in IP (immunoprecipitaion) lysis buffer (10 mM Hepes, pH 8, 100 mM NaCl, 1 mM MgCl 2 and 0.5 % Nonidet P40) containing protease inhibitors (10 μg/ml aprotinin, 0.1 mM PMSF and 10 μg/ml leupeptin) (Sigma). Lysates were incubated on ice for 10 min and centrifuged at 9300 g for 15 min at 4
• C. For fractionation, cells were lysed with 0.1 % Nonidet P40 in PBS, and the cytoplasmic and nuclear fractions were obtained essentially as described previously [23] . Samples containing the same relative volume were electrophoresed on SDS/PAGE (10 % gels) and electroblotted on to a nitrocellulose membrane (Schleicher and Schuell BioScience). Membranes were blocked with 5 % (w/v) non-fat dried skimmed milk powder and 0.1 % Tween 20 in TBS (Tris-buffered saline; 20 mM Tris/HCl, 4 mM Tris-base, 140 mM NaCl and 1 mM EDTA) for 1 h at room temperature and incubated with the primary antibodies overnight at 4
• C for 2 h at room temperature. The membranes were then washed three times in 0.1 % Tween 20 in TBS and incubated with the appropriate secondary antibodies for 1 h at room temperature. After washing, membranes were incubated with ECL (enhanced chemiluminescence) detection reagent (Santa Cruz Biotechnology) and analysed using a luminescent image analyser (Kodak X-OMAT 2000 Processor).
IP
At 48 h after transfection, cells were washed three times with ice-cold PBS and lysed as above. The corresponding supernatants were pre-cleared for 1 h at 4
• C with Protein A-agarose beads (Roche Diagnostics), after which they were centrifuged at 2300 g for 1 min at 4
• C. The supernatants were incubated for 2 h with anti-Myc antibody and overnight at 4
• C with Protein Aagarose beads. Following four washes with lysis buffer containing protease inhibitors (10 μg/ml aprotinin, 0.1 mM PMSF and 10 μg/ml leupeptin), proteins were eluted for 10 min at 100
• C with 5× loading buffer, electrophoresed on SDS/PAGE (10 % gels) and subjected to Western blotting. The corresponding blot was incubated with the appropriate antibodies.
'In-cell' SUMOylation
At 48 h after transfection of HEK-293T cells, the cells were lysed in 200 μl of denaturing buffer (1 % SDS, 50 mm Tris/HCl, pH 7.4, and 140 mm NaCl) by boiling for 10 min after vigorous vortexing. Renaturation buffer (800 μl; 2 % Triton X-100, 50 mM Tris/HCl, pH 7.4, and 140 mM NaCl) was added and, following centrifugation for 15 min at 10 000 g at 4
• C, the supernatants were subjected to immunoprecipitation and Western blot analysis as described above.
Transferrin endocytosis
Transiently transfected HeLa cells, grown on cover glasses, were incubated for 30 min in starvation medium (DMEM, 0.1 % BSA and 20 mM Hepes, pH 7.2). Following a 5 min incubation with 5 μg/ml Alexa Fluor ® 546-conjugated transferrin (Molecular Probes) at 37
• C, cells were rapidly cooled to 4
• C, washed with cold PBS, incubated with citrate buffer (25.5 mM citric acid, 24.5 mM sodium citrate, 280 mM sucrose and 0.01 mM deferoxamin, pH 4.6) for 2 min and fixed with 4 % (w/v) paraformaldehyde (Merck). The fixed cells were mounted for microscopy using galvanol mounting solution (Mowiol 4-88; Calbiochem) or Fluorescent Mounting Medium (E19-15; Golden Bridge Life Science).
Immunofluorescence and confocal microscopy
For immunofluorescence and confocal microscopy, cells were grown on cover glasses (Marienfeld) and transfected with the desired plasmids. At 24 h later, the cells were washed with PBS and fixed with 4 % (w/v) paraformaldehyde for 15 min at room temperature, followed by additional PBS washes. Permeabilization was performed with 0.1 % Triton X-100 in 50 mM Tris/HCl, pH 7.2, for 3 min at room temperature, after which cells were washed with PBS and incubated in blocking solution (20 % normal goat serum and 1 % BSA in PBS) for 30 min at room temperature. Cells were incubated with the appropriate primary antibodies that was diluted in PBS containing 1 % BSA, for 1 h at room temperature, followed by three PBS washes. The cover glasses were then incubated with the secondary antibodies in PBS containing 1 % BSA and Hoechst for 1 h at room temperature. Following washes with PBS, the cells were mounted using galvanol mounting solution or fluorescent mounting medium.
Cells were examined using Zeiss LSM 510 or Zeiss LSM 510 META confocal microscopes. For quantitative studies, all images of a given experiment were exposed and processed identically. Captured images were analysed using ImageJ software (http://rsb.info.nih.gov/ij/index.html). Pixel intensity was used to quantify fluorescence in the indicated experiments. Data was statistically evaluated using Student's t test.
Luciferase reporter assays
General transcriptional assays were performed using the pM vector (a gift from Professor Pier Paolo Di Fiore, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy), which consists of the GAL4 DNA-binding domain fused to the desired protein. EHD2 was cloned into the EcoRI and SalI sites of the pM vector by isolating an EHD2-containing fragment using the same sites. HEK-293T cells were transfected with different pM vectors and with a GAL4-TK (thymidine kinase)-luciferase reporter expressing vector.
As a specific p21WAF1/Cip1 transcription assay, HEK-293T cells were transfected with plasmids expressing Myc-KLF7, GFP-MoKA, Myc-EHD2 and a p21WAF1/Cip1-luciferase reporter [22] . All transfections included pRL-TK vector for normalization. At 48 h later, cells were lysed and luciferase activity was measured using a commercial kit (E1910, DualLuciferase Reporter Assay System; Promega). Transfection efficiencies were normalized against Renilla luciferase, expressed from the pRL-TK vector (Promega), added with each transfection (100 ng/transfection).
Yeast two-hybrid analysis
To screen the human brain library, the ORF (open reading frame) of the mouse EHD2 was cloned in-frame into the EcoRI and the XhoI restriction sites of the 'bait' pLexA vector (MATCHMAKER LexA two-hybrid system; Clontech). The EGY48 yeast strain was transformed with the pLexA/EHD2 plasmid, serving as 'bait' to screen the human brain library according the manufacturer's instructions (Clontech). The pJG4-5 vector encoding the MoKA gene was rescued and tested for interaction with yeast strains expressing the pLexA fusion protein as described above. For this, the transformed yeast colonies were first grown on glucose/histidine − /uracyl − / tryptophan − plates, and individual colonies from each transformation were assayed for growth either on galactose/raffinose/ histidine − /uracyl − /tryptophan − /leucine − or galactose/ raffinose/histidine − /uracyl − /tryptophan − /X-Gal (5-bromo-4-chloroindol-3-yl β-D-galactopyranoside) plates. Growth on leucine − plates or blue-coloured colonies on X-Gal plates indicated interaction between the bait and the prey recombinant proteins.
To test the SUMOylation of EHD2, the ORF of SUMO1 (from pcDNA-HA-SUMO1-GG, a gift from Professor Michael Nevels) was cloned in-frame into the EcoRI and the XhoI restriction sites of either the 'bait' pLexA vector or the 'prey' pJG4-5 vectors (MATCHMAKER LexA two hybrid system; Clontech) to construct the pLexA/SUMO1 and pJG4-5/SUMO1 respectively. The ORF of the mouse EHD2 was cloned into the pJG4-5 vector to construct pJG4-5/EHD2. The EGY48 yeast strain was co-transformed with pLexA/EHD2 [wt (wild-type) or mutants] and pJG4-5/SUMO1 or with pLexA/SUMO1 and pJG4-5/EHD2 (wt or mutants). The transformed yeast colonies were treated as described above.
qRT-PCR (quantitative real-time PCR)
Total RNA was isolated using the EZ-RNA Isolation kit (Biological Industries) according to the manufacturer's instructions. RNA (2 μg) was used as a template for the reverse transcriptase reaction using MMLV (Moloney murine leukaemia virus) Reverse Transcriptase (Promega) and oligo(dT) primer, according to the manufacturer's protocol. Forward and reverse primers for p21WAF1/Cip1 were: 5 -CCTCTTCGGCCCAGTGGAC-3 and 5 -CCGTTTTCGAC-CCTGAGAG-3 respectively. p21WAF1/Cip1 expression in different samples was normalized to the expression of GAPDH (glyceraldehyde-3-phosphate dehydrogenase). PCRs were performed using a RotorGene 6000 (Qiagen) and Absolute Cells were visualized using an LSM510 confocal microscope. All images were taken at maximal nuclear focus defined by Hoechst staining. A total of 50-100 cells were analysed in each type of transfection/staining and the data was statistically evaluated using Student's t test.
Blue qPCR (quantitative PCR) SYBR Green mix (Abgene). Each sample was loaded in triplicate.
Knockdown of EHD2
For knockdown of EHD2, a pLKO.1 plasmid harbouring the 5 -AAACCCAGGGCTGCCTTGGAAAAG-3 sequence (Open Biosystems) was introduced into COS7 cells and, as a control, a pLKO.1 plasmid harbouring shRNA (short hairpin RNA) against GFP was used. The expression level of EHD2 was assessed against that of β-tubulin.
RESULTS
EHD2 accumulates in the nucleus upon LMB treatment
In previous years, data have accumulated that indicated nuclear roles for endocytic proteins. In addition to the previously reported plasma membrane localization of EHD2 [9, 10] , our confocal analysis has shown a partial nuclear localization of EHD2. Therefore we decided to check whether EHD proteins are capable of nucleocytoplasmic shuttling. Considering the molecular mass of EHD proteins (∼64 kDa), bioinformatic analysis was performed in order to find a potential NLS Since GFP alone is also nuclear, the nuclear fraction, presented in (E), was quantified by dividing nuclear intensity by total cellular intensity (measured using ImageJ). The data was statistically evaluated using Student's t test.
sequence within the proteins (http://psort.nibb.ac.jp/form2.html). According to the results, EHD proteins contain a conserved bipartite NLS ( Figure 1A) . In order to confirm the ability of EHD proteins to undergo nucleocytoplasmic shuttling, nuclear accumulation of EHD1, EHD2 and EHD3 was tested in HeLa cells upon LMB-induced inhibition of nuclear exit. Vehicletreated (ethanol) cells showed the expected and previously reported localization of EHD1, EHD2 and EHD3 ( Figure 1B) . However EHD2 accumulated in the nucleus upon LMB treatment, whereas EHD1 and EHD3 remained cytoplasmic ( Figures 1B  and 1C ). We could confirm these results by staining endogenous EHD2 in LMB-treated HeLa cells, which demonstrated high nuclear staining of EHD2 compared with vehicle-treated cells ( Figures 1B and 1C) . The same results were obtained with other cell lines [COS7 and CHO (Chinese hamster ovary); results not shown]. Our results strongly indicate shuttling of EHD2 from the cytoplasm to the nucleus.
Nucleocytoplasmic shuttling of EHD2 depends on its NLS
In an attempt to reveal whether the conserved bipartite NLS in EHD2 is functional and is responsible for entry of EHD2 into the nucleus, mutation analysis was performed. Several NLS mutants were constructed, with different lysine to alanine residue substitutions (Figure 2A) , and their cellular localization was followed in LMB-treated cells. EHD2, in which all six lysine residues of the putative NLS were mutated to alanine residues (mNLS), failed to enter the nucleus (Figures 2B and 2C) Figure 2D) .
To confirm the functionality of the EHD2 NLS, it was fused, either in its native or mutated form (K327A/K328A/K329A) to GFP. Since GFP is a small protein, which can diffuse through the nuclear pores, it has both nuclear and cytoplasmic localization. However, when fused to a functional NLS, it should present a significantly higher nuclear distribution. Indeed, GFP coupled to the native NLS of EHD2 presented a higher nuclear fraction than GFP alone or GFP coupled to the mutant NLS of EHD2 ( Figures 2E and 2F) .
Interestingly, the non-nuclear localization of mNLS, as well as that of mNLS3 and mNLS4, differed from that of wt EHD2. It was mostly endosomal with practically no evidence for plasma membrane localization ( Figures 2B and 2D ). This could be due to a decrease in the charge of the protein, owing to the cancellation of charged lysine residues, which may normally contribute to plasma membrane association [24] , and to the fact that endosomal membranes have fewer charged components compared with the plasma membrane [25] .
To summarize, our results strongly suggest that the lysine residues 327-329 of EHD2 constitute an active NLS, which controls its entry into the nucleus.
Nuclear entry of EHD2 is not affected by nucleotide binding
It has previously been demonstrated that nucleotide binding affects nucleocytoplasmic shuttling of proteins [26] . Thus the NTF (nuclear transport factor)-mediated nuclear import of Ran protein depends upon its binding to GDP. The GTP-bound form of Ran cannot bind NTF2 and, therefore, is not imported into the nucleus [26] . Plasma membrane localization of EHD2 depends upon its binding to ATP [12] . In order to test whether nucleotide binding also affects the nuclear entry of EHD2, we tested the ability of a nucleotide-free mutant of EHD2, EHD2T72A [12] , to enter the nucleus. As depicted in Figure 3(A) , the absence of a bound nucleotide had no effect on the ability of EHD2 to enter the nucleus. Quantitative analysis showed that both the wt and the nucleotide-free mutant of EHD2 accumulated in the nucleus following LMB treatment ( Figure 3B ).
Nuclear exit of EHD2 depends on its Lys 315 SUMOylation and only partially on its NES sequence
In order to find the mechanism responsible for the exit of EHD2 from the nucleus, a mutational analysis of the predicted EHD2 NES sequence (http://elm.eu.org/) was performed ( Figure 4A ). Leucine to alanine residue substitutions at position 392 ( NES2) and at positions 395-396 ( NES3), did not change the cellular localization of EHD2 ( Figures 4B and 4C ). However, a substitution of L387A ( NES1) led to a partial accumulation of EHD2 in the nucleus (Figures 4B and 4C) . These results suggest that Leu 387 is important for EHD2 exit from the nucleus. However, since EHD2 mutated at Leu 387 did not exhibit nuclear retention, similar to wt EHD2 in the presence of LMB, it was obvious that additional mechanisms should be responsible for the nuclear export of EHD2. This conclusion was confirmed by our results indicating that lysine to alanine residue mutations at positions 315 and 316 of EHD2 led to its accumulation in the nucleus ( Figure 2D ). These findings strongly suggested that Lys 315 and Lys 316 are important for the nuclear exit of EHD2, most probably through a protein modification. Bioinformatic analysis highlighted Lys 315 as part of a consensus SUMOylation sequence (http://www.abgent.com/sumoplot/), two of which exist in EHD2 ( Figure 4D ).
The localization of the EHD2 variants L315A and L516A was tested. The results indicated a massive nuclear presence of EHD2 mutated at Lys 315 , similar to the EHD2 K315A/K316A mutant ( Figures 4E and 4F , see also Figure 2D ). Nuclear localization of the EHD2 K315A mutant was significantly higher than that of wt EHD2 in LMB-treated cells ( Figure 4F ), suggesting an important role for SUMOylation in nuclear exit of EHD2. However, the EHD2 K516A mutant showed a low nuclear presence, similar to wt EHD2. To eliminate the possibility that the change of charge (lysine to alanine) was responsible for the inability of the mutants to exit the nucleus, mutants containing lysing to arginine substitutions were constructed. Similar to the mutant containing lysine to alanine substitutions, EHD2 K315R showed a higher nuclear presence in comparison with the wt protein, whereas EHD2 K516R presented a classical membranal localization, similar to that of wt EHD2 (Figures 4E and 4F) .
Nuclear localization of EHD2 and its SUMOylation mutant, EHD2 K315A/K316A, was confirmed using fractionation analysis. To this end, lysates were prepared from cells overexpressing wt EHD2 or EHD2 K315A/K316A mutant, with or without LMB, and were subjected to Western blotting. As a control for fraction purity, anti-β-tubulin and anti-(lamin A/C) antibodies were employed. The results strongly indicated that, under LMB treatment or elimination of EHD2 ability to exit from the nucleus (i.e. the SUMOylation mutant), EHD2 accumulated in the nucleus (Supplementary Figure S1 at http://www.BiochemJ. org/bj/444/bj4440383add.htm). On the basis of the results from the present study, we tested SUMOylation of EHD2. To this end, HEK-293T cells were co-transfected with either wt or mutant Myc-EHD2-and HA-SUMO1-expressing plasmids. Cell lysates were prepared under denaturing conditions in order to enrich for complexes containing SUMOylated proteins, after which they were immunoprecipitated using anti-Myc antibodies and subjected to SDS/PAGE. The corresponding blot was probed with anti-Myc and anti-SUMO1 antibodies. As shown from the results presented in Figure 5 (A, section IP), only in the presence of SUMO1 did EHD2 or EHD2 K516R appear as a ladder, representing SUMOylated forms of EHD2. EHD2 K315R was not SUMOylated, indicating that Lys 315 is involved in EHD2 SUMOylation.
Since SUMOylation reflects an interaction between two proteins (SUMO and the SUMOylated substrate), yeast twohybrid analysis has been employed in several cases to explore proteins that undergo this modification [27, 28] . On the basis of the literature, we decided to exploit this technique in order to confirm SUMOylation of EHD2. As shown in Figure 5 (B), wt EHD2 interacted with SUMO1. However, mutants containing lysine to arginine or alanine substitutions at position 315 showed no interaction with the SUMO1 protein. Moreover, the mutants EHD2 K516A or EHD2 K516R did not interact with SUMO1, suggesting that Lys 516 does not undergo SUMOylation in EHD2 ( Figure 5B ). In conclusion, our results show that EHD2 undergoes SUMOylation at Lys 315 , which allows its exit from the nucleus.
Overexpression of nuclear EHD2 does not inhibit transferrin internalization
An increased expression of EHD2 leads to inhibition of transferrin internalization [9, 10] . Therefore, we tested whether overexpression of mutant EHD2, which accumulates in the nucleus, affects internalization. As expected, internalization of transferrin was significantly inhibited in cells overexressing wt EHD2. However, no blockage of transferrin internalization was observed in cells expressing the mutant EHD2 K315A/K316A ( Figure 6 ). These results strongly indicate that, when overexpressed EHD2 accumulates in the nucleus, its level at the plasma membrane is not sufficient to block internalization.
EHD2 acts as a transcriptional repressor
Several endocytic proteins that shuttle to the nucleus serve as transcription modulators [14] . To investigate a possible function of nuclear EHD2 as a regulator of transcription, we employed the GAL4-based transactivation assay. The GAL4 DNA-binding domain was fused to wt or mutant EHD2, both of which were tested for their ability to affect transcription, as the 'activation domain' in this system. The vectors were co-transfected with a reporter plasmid encoding the luciferase gene under the transcriptional control of a GAL4-responsive element. Whereas E2F1, a well established transcription factor [29] , presented the expected elevation in luciferase activity, compared with the basal luciferase level obtained with GAL4 alone, a statistically significant decrease in luciferase activity was detected in the presence of EHD2 ( Figure 7A ). The level of luciferase activity obtained in the presence of mutant EHD2, which accumulates in the nucleus ( Figure 2D ), was not significantly lower than that obtained in the presence of wt EHD2 ( Figure 7A ). Our findings suggest a role for EHD2 as a corepressor of transcription.
In an attempt to identify direct genes whose transcription is regulated by EHD2, we employed the yeast two-hybrid analysis, hoping to find known transcription regulators. MoKA was found as a new EHD2 interactor ( Figure 7B ). The association between EHD2 and MoKA was verified using a co-IP assay ( Figure 7C ). MoKA is an F-box-containing protein, which undergoes nucleocytoplasmic shuttling and stimulates the activity of the transcription factor KLF7 [22, 30] . We therefore tested whether Luciferase activity was measured 48 h after transfection. Results represent five independent experiments performed in triplicate. The data was statistically evaluated using Student's t test. (E) HEK-293T cells were transiently transfected with Myc-EHD2 (EHD2), Myc-EHD2 K315A/K316A (EHD2KK315-316AA) or GFP-EHD2 mNLS (EHD2mNLS) and real-time PCR experiments were performed using p21 gene-specific primers. Each sample was loaded in triplicate and experiments were repeated at least three times. Expression was normalized to that of GAPDH. The data was statistically evaluated using Student's t test. (F) COS7 cells were transiently transfected with Myc-EHD2 or plasmids expressing either shRNA against EHD2 (shRNA EHD2) or shRNA against GFP (shRNA GFP), as a control. Real-time PCR experiments were performed using p21 gene-specific primers. Expression was normalized to that of GAPDH. Each sample was tested in triplicate and experiments were repeated at least three times. The expression of EHD2 was evaluated by Western blot analysis using anti-EHD2 antibodies (Abcam) and anti-β-tubulin as a loading control.
EHD2 is engaged in repression of MoKA-modulated KLF7 activity. HEK-293T cells were co-transfected with plasmids expressing Myc-KLF7 together with Myc-EHD2, GFPMoKA and the luciferase reporter gene under the promoter of p21WAF1/Cip1, a promoter with a known binding site for KLF7 [22] . p21WAF1/Cip1 is a CDK (cyclin-dependent kinase) inhibitor, which is important in the response of cells to genotoxic stress. It binds to and inhibits the activity of CDK1 and CDK2 and blocks the transition from G 1 into S-phase or from G 2 into mitosis after DNA damage [31] . A decrease in luciferase activity, directed from the p21WAF1/Cip1 promoter, was observed in the presence of wt or nuclear EHD2 mutant, compared with the basal activity ( Figure 7D ). As expected, KLF7 or both KLF7 and MoKA induced luciferase activity, directed from the p21WAF1/Cip1 promoter, whereas the addition of EHD2 to KLF7 alone or to both KLF7 and MoKA decreased the level of luminescence ( Figure 7D) . Moreover, the SUMOylation mutant of EHD2 (EHD2 K315A/K316A), which accumulates in the nucleus, significantly reduced KLF7-regulated or MoKA-modulated/KLF7-regulated transcription from the p21WAF1/Cip1 promoter ( Figure 7D ). It is worth mentioning that the large variation in the level of luminescence directed by KLF7 and MoKA (with or without EHD2) is due to the variability in expression of MoKA we encountered in the different experiments.
In order to test the effect of EHD2 on endogenous levels of p21WAF1/Cip1, qRT-PCR experiments were performed in the presence of either overexpressed EHD2 or under knockdown conditions. A significant decrease in p21WAF1/Cip1 mRNA [CDKN1A (CDK inhibitor 1A)] level was observed in HEK-293T cells expressing either Myc-EHD2 or Myc-EHD2 K315A/K316A, whereas expression of EHD2 lacking its NLS sequence (EHD2 mNLS) did not cause any reduction in transcription of p21WAF1/Cip1 ( Figure 7E ). These results suggest that the entrance of EHD2 into the nucleus is essential for its function as a transcriptional corepressor. Knockdown of EHD2 significantly increased the mRNA level of p21WAF1/Cip1 in comparison with control conditions (transfection with shRNA against GFP), suggesting that EHD2 is involved in repression of transcription of p21WAF1/Cip1 ( Figure 7F ). Taken together, our results indicate that EHD2 represses KLF7-regulated transcription of p21WAF1/Cip1.
DISCUSSION
In the present study we show that EHD2 is a nucleocytoplasmic shuttling protein. Its entry into the nucleus depends on Lys 327 -Lys 329 of its NLS and its exit from the nucleus depends mainly on its SUMOylation at Lys 315 and partially on its NES Leu 387 . Our results strongly indicated that nuclear EHD2 acts as a transcription corepressor. It did so in a general GAL4-based transcription assay and in a more specific KLF-regulated and MoKA co-activated transcription of p21WAF1/Cip1. We refer to EHD2 as a corepressor since it does not have any protein modules that underscore transcription factors, such as: helix-loop-helix, helixturn-helix, zinc finger(s) or leucine zipper [32] .
KLF7 was identified as an important regulator of differentiation as well as proliferation state in neuronal tissues during embryonic development. It was found to stimulate the transcription of CDK inhibitors, such as p21WAF1/Cip1 and p27kip1, which contribute to progression of neuronal differentiation and therefore down-regulate proliferation [33] [34] [35] . On the basis of our results, we speculate that EHD2 contributes to fine-tuning of neuronal differentiation by down-regulating transcriptional activity of KLF7. This down-regulation may be mediated through interaction with MoKA or MoKA together with KLF7. We hypothesize that EHD2 represses transcription in other tissues as well, on the basis of its expression pattern, by interacting with other, yet unknown, transcription factors. Microarray chip analysis of RNA from EHD2-overexpressing cells will indicate possible genes whose transcription is modulated by EHD2.
In the past decade, a number of endocytic proteins have been shown to shuttle to the nucleus [14] . Eps15 is a well-characterized endocytic protein, which was shown to regulate internalization of EGFR (epidermal growth factor receptor) and transferrin receptor by binding to the core proteins of endocytic trafficking, such as the AP2 (adaptor protein 2) complex [36, 37] . CALM interacts with clathrin and the AP2 complex and regulates progression of coated bud formation at the plasma membrane [38] . Eps15 and CALM shuttle to the nucleus and positively regulate transcription [39] . Epsin1, an interactor of Eps15, which was shown to promote clathrin assembly in the synapse [40] , undergoes nucleocytoplasmic shuttling, and interacts with the transcription factor PLZF (promyelocytic leukaemia zinc finger) [41] . Dab1 and Dab2, plasma membrane associated adaptors that are involved in endocytosis, were also shown to traffic to the nucleus [42, 43] , where Dab2 functions as a co-activator of TGFβ-dependent transcription [43] . On the other hand, APPL1 (adaptor protein, phosphotyrosine interaction, pleckstrin homology domain and leucine zipper containing 1), which associates with endosomal membranes and promotes membrane bending through its BAR (Bin/amphiphysin/Rvs) domain [44] , was shown to interact in the nucleus with the NuRD (nucleosome remodelling and histone deacetylase) corepressor complex [45] [46] [47] . Thus endocytic proteins that shuttle to the nucleus may serve as co-activators or corepressors. Our results strongly suggest that EHD2 belongs to the corepressors group of nucleocytoplasmic shuttling proteins.
As far as we know, EHD2 is the first plasma-membraneassociated endocytic protein that shuttles to the nucleus and undergoes SUMOylation. Our results showed that nuclear exit of EHD2 depends upon SUMOylation of Lys 315 . SUMOylation of a protein may affect its stability, interactions, intracellular localization or biological activity. In the cytoplasm, SUMOylation has previously been documented for proteins that participate in mitochondrial dynamics, endoplasmic reticulum signalling and for plasma membrane receptors. Concerning mitochondrial dynamics, reversible SUMOylation of DRP1 (dynamin-related protein 1), a cytosolic dynamin-like GTPase, is necessary to maintain the balance between mitochondrial fission and fusion [48, 49] . PTP1B (protein tyrosine phosphatase 1B) localizes to the cytoplasmic faces of the endoplasmic reticulum and the nuclear envelope. It negatively regulates growth factor signalling and cell proliferation by dephosphorylating key receptor tyrosine kinases. Insulin treatment stimulates SUMOylation of PTP1B, thereby impairing its activity. These results suggest a positive role for SUMOylation in receptor kinase signalling. Likewise, the SUMOylation of the plasma membrane receptor voltage-gated potassium channel Kv1.5 changes its activity [50] . Another SUMO target at the plasma membrane is the GluR6 (glutamate receptor 6) subunit of the kainite receptor, whose SUMOylation promotes its endocytosis [51] .
SUMOylation affects nucleocytoplasmic trafficking of proteins and alters the ability of proteins to bind to DNA [52] . Upon TGFβ stimulation, mediated by the TGFβ receptors, Smad3 is phosphorylated in the cytoplasm and shuttles to the nucleus, where it regulates transcription of genes by indirect binding to DNA through interactions with co-activators {p300-and CBP [CREB (cAMP-response-element-binding protein)-binding protein]-associating factors} and corepressors (histone deacetylase or its recruiting partners) [53, 54] . Smad3 SUMOylation disrupts its ability to bind to DNA and enhances its nuclear export [55] . Bovine papillomavirus E1 protein undergoes export from the nucleus through interaction of its NES sequence with CRM1 exportin. SUMOylation stimulates this interaction, thus promoting trafficking of E1 from the nucleus [56] . Since cancellation of predicted NES sequence in EHD2 did not lead to a maximal accumulation of the protein inside the nucleus, it is possible that SUMOylation of EHD2 contributes to the interaction of EHD2 with CRM1 exportin, thus enhancing the exit of EHD2 from the nucleus.
To conclude, the results presented in this study highlight a new biological function of the plasma-membrane-associated endocytic protein EHD2, demonstrating it as a nucleocytoplasmic shuttling protein with a function as a corepressor of transcription in the nucleus.
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